Within the UMCG Particle Therapy Research Center (PARTREC), which is embedded in the Departments of Radiation Oncology and Biomedical Sciences of Cells and Systems of the UMCG, we are looking for a post-doctoral fellow in radiation physics to strengthen our multi-disciplinary preclinical particle therapy research programme.
The successful candidate will contribute to the realization of a new research infrastructure for image guided particle irradiations in preclinical radiation biology research at the UMCG Particle Therapy Research Center. (S)he will be part of the PARTREC Radiation Physics group, which consists of five faculty and several PhD-students and post-docs and is an integral part of the Medical Physics and Instrumentation Division of the UMCG Department of Radiation Oncology.
UMCG Particle Therapy Research Center
UMCG foresees a central role for particle therapy in general and proton therapy in particular, both in patient care and clinical research at the UMCG Groningen Proton Therapy Center and in radiation biology and physics research at its newly established Particle therapy Research Center. Our strategic research priorities are related to the physics and biology of particle therapy with a special focus on proton therapy.
UMCG PARTREC operates a large superconducting cyclotron for experimental research, mainly in radiation physics and biology to support further development of radiotherapy with ion beams. For this research program the cyclotron delivers beams of various ions ranging from protons to oxygen with energies up to 190 MeV for protons and 90 MeV per nucleon for ions of helium to oxygen. The accelerator is furthermore used for research in nuclear physics by faculty of the University of Groningen and for radiation hardness testing by science and industry. Some 25 fte of technical staff operate the accelerator facility and provide the support to design, build and operate experimental stations.
UMCG PARTREC promotes multidisciplinary research in which radiation physics and biology, imaging, big-data analysis and clinical research come together to improve the quality of proton therapy treatment and explore potential benefits of other particles for cancer treatment. At UMCG, there are currently over 30 PhD students and post graduates are dedicated to particle therapy research. UMCG PARTREC is a dedicated research facility functioning in synergy with the UMCG Groningen Proton Therapy Center (GPTC). Therefore, UMCG PARTREC has the ability to uniquely combine technology development, preclinical and patient studies with an R&D program to demonstrate clinical and economic benefits and to continuously improve proton therapy technology and the treatment itself, while also assessing the feasibility of other particles for high precision radiotherapy. This combination offers unique career development opportunities in the field of Medical Physics.
The UMCG PARTREC accelerator facility is well integrated in the research landscape and participates in various EU-projects. The facility is open to the worldwide scientific community and industry.
Currently a new research infrastructure for image guided preclinical irradiations (IMPACT), supported by an infrastructure grant awarded by the Dutch Cancer Society, is under development. It is expected to be fully operational by 2024. At this new infrastructure also novel irradiation modalities such as FLASH (ultra high dose rate) and spatially fractionated radiotherapy with proton and helium beams will be available for users.